Highlight of 2023: Unlocking the therapeutic potential of natural killer cells—advances in adaptive functions, cellular engineering and immunotherapy.

This article highlights the recent advances in natural killer (NK) cell biology and their potential therapeutic applications in cancer and infectious diseases. NK cells are a crucial component of the innate immune system and have the ability to rapidly respond and eliminate infected and cancerous cells. The article discusses the development of engineered NK cell therapies, the discovery of memory NK cells with adaptive features, the impact of SARS-CoV-2 infection on NK cell behavior, the regulation of NK cells in cancer, and the use of feeder cells to expand NK cells for cellular therapies. These advancements deepen our understanding of the immune system and have the potential to transform patient care in the fight against infectious diseases and cancer. [Extracted from the article]

Copyright of Immunology & Cell Biology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)